USPTO serial 75215282
NEOTROFIN
Reviewed by CopyMark Law Group
Reg. 2643087Status 710
- Filing date
- Status date
- Registration date
- Oct 29, 2002
- Examiner
- SNAPP, TINA LOUISE
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with NEOTROFIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Irvine, CA
Irvine, CA
Irvine, CA
IRVINE, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Louis C. Cullman
Louis C. Cullman K&L Gates, LLP1900 Main Street, Suite 600Irvine, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical compounds that act on the central nervous system to treat neurodegenerative diseases and conditions such as memory deficits associated with Alzheimer's disease, impairment associated with the dementia of aging, stroke, and the neurological aspects of AIDS, as well as spinal cord injuries, expressly excluding pharmaceuticals for the treatment of amyotrophic lateral sclerosis, multiple sclerois and/or peripheral neuropathy | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NeoTherapeutics, Inc.
- Other trademarks owned by NeoTherapeutics, Inc.
- Other trademarks owned by NeoTherapeutics, Inc.
- Other trademarks owned by SPECTRUM PHARMACEUTIALS, INC.
- Other trademarks in Class 005
- Similar marks named NEOTROFIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2009 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 21, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 19, 2008 | CFIT | CASE FILE IN TICRS | — |
| Sep 5, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 29, 2002 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2002 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 8, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 2, 2002 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 5, 2002 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 28, 2002 | PETG | PETITION TO REVIVE-GRANTED | — |
| May 15, 2002 | IUAF | USE AMENDMENT FILED | — |
| Jan 18, 2002 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 28, 2001 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 14, 2001 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 14, 2001 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Jun 4, 2001 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 10, 2001 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 18, 2001 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 18, 2000 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 30, 2000 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| May 30, 2000 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Mar 5, 1998 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Oct 21, 1997 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 23, 1997 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 1997 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 16, 1997 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 8, 1997 | DOCK | ASSIGNED TO EXAMINER | — |